Thereby, the evidence points that a complete understanding of MBNL1-AS1/miR-423-5p/CREBZF axis in regulating breast cancer development is required, and that it could be seen as a biomarker in predicating survival of breast cancer patients. This evidence concerns the gene MBNL1 and breast carcinoma.